The pancreas is organized into two compartments: the exocrine and the endocrine pancreas. The latter consists of functional units named islets of Langerhans which contain five cell subtypes, α, β, δ, ε and PP-cells responsible for the secretion of glucagon, insulin, somatostatin, ghrelin and pancreatic polypeptide, respectively. Type 1 Diabetes...
-
December 2, 2016 (v1)PublicationUploaded on: December 4, 2022
-
September 5, 2013 (v1)Journal article
Type 1 diabetes (T1DM) is a common metabolic disorder affecting an ever-increasing number of patients worldwide. T1DM is caused by the selective destruction of pancreatic insulin-producing β-cells by the immune system. Such loss results in chronic hyperglycemia and could induce a number of cardio-vascular complications. Despite the classical...
Uploaded on: December 2, 2022 -
2013 (v1)Journal article
Type 1 diabetes is a metabolic disease resulting in the selective loss of pancreatic insulin-producing β-cells and affecting millions of people worldwide. The side effects of diabetes are varied and include cardiovascular, neuropathologic, and kidney diseases. Despite the most recent advances in diabetes care, patients suffering from type 1...
Uploaded on: December 3, 2022 -
2013 (v1)Journal article
Type 1 diabetes is a metabolic disease resulting in the selective loss of pancreatic insulin-producing β-cells and affecting millions of people worldwide. The side effects of diabetes are varied and include cardiovascular, neuropathologic, and kidney diseases. Despite the most recent advances in diabetes care, patients suffering from type 1...
Uploaded on: October 11, 2023 -
September 5, 2013 (v1)Journal article
Type 1 diabetes (T1DM) is a common metabolic disorder affecting an ever-increasing number of patients worldwide. T1DM is caused by the selective destruction of pancreatic insulin-producing β-cells by the immune system. Such loss results in chronic hyperglycemia and could induce a number of cardio-vascular complications. Despite the classical...
Uploaded on: October 11, 2023 -
February 1, 2013 (v1)Journal article
Diabetes mellitus represents a major healthcare burden and, due to the increasing prevalence of type I diabetes and the complications arising from current treatments, other alternative therapies must be found. Type I diabetes arises as a result of a cell-mediated autoimmune destruction of insulin producing pancreatic β-cells. Thus, a cell...
Uploaded on: December 3, 2022 -
December 2017 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
September 13, 2013 (v1)Journal article
International audience
Uploaded on: October 11, 2023 -
September 13, 2013 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
July 19, 2017 (v1)Journal article
International audience
Uploaded on: July 2, 2024 -
October 2013 (v1)Journal article
Recently, it was demonstrated that pancreatic new-born glucagon-producing cells can regenerate and convert into insulin-producing β-like cells through the ectopic expression of a single gene, Pax4. Here, combining conditional loss-of-function and lineage tracing approaches, we show that the selective inhibition of the Arx gene in α-cells is...
Uploaded on: December 3, 2022 -
October 2013 (v1)Journal article
Recently, it was demonstrated that pancreatic new-born glucagon-producing cells can regenerate and convert into insulin-producing β-like cells through the ectopic expression of a single gene, Pax4. Here, combining conditional loss-of-function and lineage tracing approaches, we show that the selective inhibition of the Arx gene in α-cells is...
Uploaded on: October 11, 2023 -
June 25, 2013 (v1)Journal article
It was recently demonstrated that embryonic glucagon-producing cells in the pancreas can regenerate and convert into insulin-producing β-like cells through the constitutive/ectopic expression of the Pax4 gene. However, whether α cells in adult mice display the same plasticity is unknown. Similarly, the mechanisms underlying such reprogramming...
Uploaded on: December 2, 2022 -
January 12, 2017 (v1)Journal article
The recent discovery that genetically modified α cells can regenerate and convert into β-like cells in vivo holds great promise for diabetes research. However, to eventually translate these findings to human, it is crucial to discover compounds with similar activities. Herein, we report the identification of GABA as an inducer of α-to-β-like...
Uploaded on: December 4, 2022